4.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$4.425
Aprire:
$4.405
Volume 24 ore:
1.22M
Relative Volume:
0.24
Capitalizzazione di mercato:
$1.05B
Reddito:
$251.85M
Utile/perdita netta:
$-72.58M
Rapporto P/E:
-14.01
EPS:
-0.3134
Flusso di cassa netto:
$-63.80M
1 W Prestazione:
-4.57%
1M Prestazione:
+20.94%
6M Prestazione:
-20.33%
1 anno Prestazione:
-22.85%
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ARDX
Ardelyx Inc
|
4.39 | 1.06B | 251.85M | -72.58M | -63.80M | -0.3134 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-18 | Ripresa | H.C. Wainwright | Buy |
2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
2025-03-04 | Iniziato | BTIG Research | Buy |
2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
2024-04-05 | Iniziato | Leerink Partners | Outperform |
2023-12-18 | Iniziato | Raymond James | Strong Buy |
2023-09-07 | Iniziato | H.C. Wainwright | Buy |
2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | Downgrade | Jefferies | Buy → Hold |
2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
2021-03-23 | Iniziato | Wedbush | Outperform |
2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
2020-10-20 | Ripresa | Citigroup | Buy |
2020-02-18 | Ripresa | Jefferies | Buy |
2020-02-12 | Iniziato | Citigroup | Buy |
2020-02-10 | Iniziato | Cowen | Outperform |
2019-04-08 | Iniziato | Piper Jaffray | Overweight |
2018-08-24 | Iniziato | Jefferies | Buy |
2018-03-19 | Ripresa | Leerink Partners | Outperform |
2017-11-29 | Reiterato | Citigroup | Buy |
2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
2017-10-17 | Ripresa | Leerink Partners | Outperform |
2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx (ARDX) Announced New data for IBSRELA - MSN
What drives Ardelyx Inc. stock priceUnstoppable profit momentum - Autocar Professional
Is Ardelyx Inc. a good long term investmentConsistent triple returns - jammulinksnews.com
What analysts say about Ardelyx Inc. stockFree Capital Allocation Plans - jammulinksnews.com
11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey
5 stocks with growth potential: SOUN, JBL, MNTN, ARDX, RCEL - Markets.com
Ardelyx Announces Q2 2025 Financial Results Conference Call - AInvest
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 - The Globe and Mail
Ardelyx Inc. Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional
Lobbying Update: $540,000 of ARDELYX INC. lobbying was just disclosed - Nasdaq
Wedbush Issues Negative Outlook for Ardelyx Earnings - MarketBeat
This Small-Cap Stock Could 10x By 2030, But It’s Not For The Faint Of Heart - Barchart.com
Wedbush Raises Price Target on Ardelyx to $13 From $11, Keeps Outperform Rating - MarketScreener
Long Term Trading Analysis for (ARDX) - news.stocktradersdaily.com
Jefferies Maintains a Buy Rating on Ardelyx (ARDX) With an $8 Price Target - MSN
Lobbying Update: $50,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st
Ardelyx Faces An Uphill Battle Despite Oral Arguments Set In XPHOZAH Appeal (NASDAQ:ARDX) - Seeking Alpha
Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock - Investing.com
Cantor Fitzgerald reiterates Overweight rating on Ardelyx stock By Investing.com - Investing.com Nigeria
Ardelyx (ARDX) Appoints New Chief Business and HR Officers - MSN
Leerink Partners Maintains a Buy Rating on Ardelyx (ARDX) With a $10 PT - MSN
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 – ARDX - ACCESS Newswire
Ardelyx amends loan agreement to draw $50 million and secures future options - Investing.com
Ardelyx spike attributed to Xphozah legal update - MSN
Ardelyx stock spike attributed to Xphozah update (ARDX:NASDAQ) - Seeking Alpha
(ARDX) Trading Signals - news.stocktradersdaily.com
A biopharma bolsters patient centricity and trial diversity goals through newly created role - Yahoo Finance
10 Best Healthcare Penny Stocks to Buy According to Analysts - Insider Monkey
Two Beaten-Down Biotech Stocks See Big Insider Buys - Barron's
H.C. Wainwright Initiates Coverage of Ardelyx (ARDX) Stock, Gives Buy - MSN
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):